Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:58 PM
Ignite Modification Date:
2025-12-24 @ 5:58 PM
NCT ID:
NCT05846568
Eligibility Criteria:
Inclusion Criteria:
1. Chinese males or females aged 18 years or above on Study Day 0 with legal identification documents and plan to live in the local area during the study;
2. WHO Category III rabies exposure；
3. Those who have an armpit temperature ≤ 37.0 °C；
4. Completed written informed consent process, signed the informed consent forms and Agreed to complete all follow-ups.
Exclusion Criteria:
1. WHO Category III rabies exposure but received wound suture treatment;
2. WHO Category III rabies exposure over 72 hours;
3. Previous receipt of rabies vaccination or rabies passive immunization;
4. History of bitten by animals such as dogs, cats, bats etc. within the 6 months before the Study Day 0;
5. History of any severe allergy for vaccination;
6. Had fever (armpit temperature ≥ 38.5 °C) or received any antipyretic, analgesic or anti-allergic drug within 3 days before Study Day 0;
7. History of severe autoimmune diseases;
8. History of any severe neurological disease；
9. History of receiving any immunoglobulin or vaccine within 30 days before Study Day 0, or plan to use any such product during the study;
10. History of addiction to any narcotic, alcohol or drugs;
11. Previous receipt of any study product (drug, vaccine, biological product or device) within 6 months before Study Day 0, or plan to participate in any other clinical study during this study period;
12. Females who are pregnant or with urine pregnancy test positive.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05846568
Study Brief:
Protocol Section:
NCT05846568